{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T03:45:54Z","timestamp":1776311154270,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2001,5,1]],"date-time":"2001-05-01T00:00:00Z","timestamp":988675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2001,5,1]],"date-time":"2001-05-01T00:00:00Z","timestamp":988675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01GB9708"],"award-info":[{"award-number":["01GB9708"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017118","name":"FORUM Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017118","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2001,5]]},"DOI":"10.1016\/s0002-9440(10)64123-5","type":"journal-article","created":{"date-parts":[[2011,1,28]],"date-time":"2011-01-28T00:02:54Z","timestamp":1296172974000},"page":"1677-1683","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":188,"title":["Allelic Loss Is Often the First Hit in the Biallelic Inactivation of the p53 and DPC4 Genes During Pancreatic Carcinogenesis"],"prefix":"10.1016","volume":"158","author":[{"given":"Jutta","family":"L\u00fcttges","sequence":"first","affiliation":[]},{"given":"Hamid","family":"Galehdari","sequence":"additional","affiliation":[]},{"given":"Verena","family":"Br\u00f6cker","sequence":"additional","affiliation":[]},{"given":"Irmgard","family":"Schwarte-Waldhoff","sequence":"additional","affiliation":[]},{"given":"Doris","family":"Henne-Bruns","sequence":"additional","affiliation":[]},{"given":"G\u00fcnter","family":"Kl\u00f6ppel","sequence":"additional","affiliation":[]},{"given":"Wolff","family":"Schmiegel","sequence":"additional","affiliation":[]},{"given":"Stephan A.","family":"Hahn","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0002-9440(10)64123-5_bib1","first-page":"2690","article-title":"Morphological lesions associated with human primary invasive carcinoma nonendocrine pancreas cancer","volume":"36","author":"Cubilla","year":"1976","journal-title":"Cancer Res"},{"key":"10.1016\/S0002-9440(10)64123-5_bib2","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1002\/1097-0142(197904)43:4<1418::AID-CNCR2820430431>3.0.CO;2-O","article-title":"Relation of pancreatic duct hyperplasia to carcinoma","volume":"43","author":"Kozuka","year":"1979","journal-title":"Cancer"},{"key":"10.1016\/S0002-9440(10)64123-5_bib3","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF00430702","article-title":"Intraductal proliferation in the pancreas and its relationship to human and experimental carcinogenesis","volume":"387","author":"Kl\u00f6ppel","year":"1980","journal-title":"Virchows Arch Pathol Anat"},{"key":"10.1016\/S0002-9440(10)64123-5_bib4","unstructured":"Hruban RH, Adsay NV, Albores-Saavedra J, Compton C, Garrett ES, Goodman SN, Kern SE, Klimstra D, Kl\u00f6ppel G, Longnecker DL, L\u00fcttges J, Offerhaus GJA: Pancreatic intraepithelial neoplasia (PanIN): a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol (in press)"},{"key":"10.1016\/S0002-9440(10)64123-5_bib5","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1053\/gast.1996.v110.pm8536861","article-title":"Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease","volume":"110","author":"Tada","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/S0002-9440(10)64123-5_bib6","first-page":"2140","article-title":"p16 and K-ras mutations in the intraductal precursors of human pancreatic adenocarcinoma","volume":"57","author":"Moskaluk","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/S0002-9440(10)64123-5_bib7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/BF02821606","article-title":"K-ras mutations and allelic loss at 5q and 18q in the development of human pancreatic cancers","volume":"21","author":"Sugio","year":"1997","journal-title":"Int J Pancreatol"},{"key":"10.1016\/S0002-9440(10)64123-5_bib8","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s004280050428","article-title":"Duct changes and K-ras mutations in the disease-free pancreas: analysis of type, age relation and spatial distribution","volume":"435","author":"L\u00fcttges","year":"1999","journal-title":"Virchows Arch"},{"key":"10.1016\/S0002-9440(10)64123-5_bib9","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1002\/(SICI)1097-0142(19990415)85:8<1703::AID-CNCR9>3.0.CO;2-R","article-title":"The K-ras mutation pattern in pancreatic ductal adenocarcinoma is usually identical to that in associated normal, hyperplastic and metaplastic duct epithelium","volume":"85","author":"L\u00fcttges","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/S0002-9440(10)64123-5_bib10","first-page":"4740","article-title":"Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression","volume":"58","author":"Wilentz","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/S0002-9440(10)64123-5_bib11","first-page":"1291","article-title":"Expression of p53 protein in precursor lesions and adenocarcinoma of human pancreas","volume":"145","author":"Boschman","year":"1994","journal-title":"Am J Pathol"},{"key":"10.1016\/S0002-9440(10)64123-5_bib12","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/ajcp\/101.6.684","article-title":"Overexpression of p53 protein in adenocarcinoma of the pancreas","volume":"101","author":"DiGiuseppe","year":"1994","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/S0002-9440(10)64123-5_bib13","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0002-9440(10)64520-8","article-title":"Molecular analysis of microdissected tumors and preneoplastic intraductal lesions in pancreatic carcinoma","volume":"157","author":"Heinm\u00f6ller","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/S0002-9440(10)64123-5_bib14","first-page":"2002","article-title":"Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression","volume":"60","author":"Wilentz","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/S0002-9440(10)64123-5_bib15","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1016\/S0002-9440(10)65083-3","article-title":"Genetic progression and divergence in pancreatic carcinoma","volume":"156","author":"Yamano","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/S0002-9440(10)64123-5_bib16","doi-asserted-by":"crossref","first-page":"14676","DOI":"10.1073\/pnas.93.25.14676","article-title":"Whole genome amplification using a degenerate oligonucleotide primer allows hundreds of genotypes to be performed on less than one nanogram of genomic DNA","volume":"93","author":"Cheung","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0002-9440(10)64123-5_bib17","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1002\/1097-0142(20000601)88:11<2495::AID-CNCR10>3.0.CO;2-B","article-title":"Ductal lesions in patients with chorionic pancreatitis show K-ras mutations in a frequency similar to that in the normal pancreas and lack nuclear immunoreactivity for p53","volume":"88","author":"L\u00fcttges","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/S0002-9440(10)64123-5_bib18","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0002-9440(10)64703-7","article-title":"Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas: a new marker of DPC4 inactivation","volume":"156","author":"Wilentz","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/S0002-9440(10)64123-5_bib19","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/S0002-9440(10)65054-7","article-title":"Genetic progression in the pancreatic ducts","volume":"156","author":"Hruban","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/S0002-9440(10)64123-5_bib20","first-page":"289","article-title":"p53 and K-RAS alterations in pancreatic epithelial cell lesions","volume":"8","author":"Kalthoff","year":"1993","journal-title":"Oncogene"},{"key":"10.1016\/S0002-9440(10)64123-5_bib21","first-page":"3025","article-title":"p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions","volume":"54","author":"Redston","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/S0002-9440(10)64123-5_bib22","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1126\/science.271.5247.350","article-title":"DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1","volume":"271","author":"Hahn","year":"1996","journal-title":"Science"},{"key":"10.1016\/S0002-9440(10)64123-5_bib23","first-page":"4222","article-title":"Loss of chromosome 18q is an early event in pancreatic ductal tumorigenesis","volume":"58","author":"Fukushige","year":"1998","journal-title":"Cancer Res"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944010641235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944010641235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:56:37Z","timestamp":1762080997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944010641235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,5]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2001,5]]}},"alternative-id":["S0002944010641235"],"URL":"https:\/\/doi.org\/10.1016\/s0002-9440(10)64123-5","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2001,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Allelic Loss Is Often the First Hit in the Biallelic Inactivation of the p53 and DPC4 Genes During Pancreatic Carcinogenesis","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0002-9440(10)64123-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2001 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}